Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_assertion type Assertion NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_head.
- NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_assertion description "[In the present study, we investigated marvelD3 expression in well and poorly differentiated human pancreatic cancer cell lines and normal pancreatic duct epithelial cells in which the hTERT gene was introduced into human pancreatic duct epithelial cells in primary culture, and the changes of marvelD3 during Snail-induced epithelial-mesenchymal transition (EMT) under hypoxia, TGF-? treatment and knockdown of FOXA2 in well differentiated pancreatic cancer HPAC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_provenance.
- NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_assertion evidence source_evidence_literature NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_provenance.
- NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_assertion SIO_000772 21763689 NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_provenance.
- NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_assertion wasDerivedFrom befree-2016 NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_provenance.
- NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_assertion wasGeneratedBy ECO_0000203 NP910226.RAku_Ddk6CzYzpfKPlfjGpqd5m1L9v3TB7k53_fsg2rLM130_provenance.